PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.41%
Revenue growth at 75-90% of NXPI's 3.21%. Bill Ackman would push for innovation or market expansion to catch up.
-0.40%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
3.22%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
3.22%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
-11.18%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-10.20%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.53%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.52%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.23%
Dividend reduction while NXPI stands at 0.12%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-19.03%
Negative OCF growth while NXPI is at 37.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-41.00%
Negative FCF growth while NXPI is at 94.26%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
83.22%
Similar 10Y revenue/share CAGR to NXPI's 79.10%. Walter Schloss might see both firms benefiting from the same long-term demand.
87.61%
5Y revenue/share CAGR 1.25-1.5x NXPI's 77.31%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
27.99%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
99.01%
10Y OCF/share CAGR in line with NXPI's 104.58%. Walter Schloss would see both as similarly efficient over the decade.
79.80%
5Y OCF/share CAGR at 50-75% of NXPI's 107.18%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-22.36%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
1239.80%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
536.36%
5Y net income/share CAGR above 1.5x NXPI's 328.95%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
15.83%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
98.52%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
19.49%
5Y equity/share CAGR is in line with NXPI's 18.89%. Walter Schloss would see parallel mid-term profitability and retention policies.
7.75%
Below 50% of NXPI's 42.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
373.94%
Dividend/share CAGR of 373.94% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
367.18%
5Y dividend/share CAGR above 1.5x NXPI's 169.49%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
298.29%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
8.51%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.63%
Inventory growth well above NXPI's 0.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.36%
Asset growth 1.25-1.5x NXPI's 0.28%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
1.83%
50-75% of NXPI's 3.20%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-5.06%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.61%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.